BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patie
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
| (NASDAQ: BNTX) | Delayed: 91.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.29 | 52 Week High | $ | |||
| Open | $91.29 | 52 Week Low | $ | |||
| Day High | $91.29 | P/E | N/A | |||
| Day Low | $91.29 | EPS | $ | |||
| Volume | 3,695 | |||||
